Quarterly and annual results disclosed under 8-K Item 2.02.
Purple Innovation, Inc. reported the full year 2026 results: revenue in the range of $500 to $520 million. Guidance initiated.
“For 2026, the Company currently expects full year revenue to be in the range of $500 to $520 million and adjusted EBITDA in the range of $20 to $30 million.”
Purple Innovation, Inc. reported the calendar year ended December 31, 2025 results: revenue $468.7 million, net income $(51.4) million.
“Full year 2025 net revenue was $468.7 million, a decline of 3.9% compared to the full year 2024.”
Purple Innovation, Inc. reported the fourth quarter ended December 31, 2025 results: revenue $140.7 million, net income $3.2 million.
“cost structure, supported by what we believe is a clear and disciplined strategy to scale profitably.” Fourth Quarter 2025 Financial Results Fourth quarter 2025 net revenue was $140.7 million, representing growth of approximately 9.1% compared to the fourth quarter of 2024. Growth was driven primarily by the wholesale channel, reflecting a full quarter of expanded”
BEYOND MEAT, INC. reported financial results for the fourth quarter and fiscal year ended December 31, 2025.
“On March 31, 2026, Beyond Meat, Inc. (the “Company”) issued a press release announcing its financial results for the fourth quarter and fiscal year ended December 31, 2025.”
KULR Technology Group, Inc. reported the year ended December 31, 2025 results: revenue $16,170,404, net income $61,899,782, EPS loss of $1.56 per share.
“Revenue increased 51% to $16,170,404 in 2025 from $10,737,481 in 2024.”
KULR Technology Group, Inc. reported the fourth quarter ended December 31, 2025 results: revenue $2,863,961, net income $44,261,358, EPS loss of $.97 per share.
“and confidence in our ability to convert technical leadership into long-term shareholder value.” Fourth Quarter 2025 Financial Results: Revenues: Revenue decreased 15% to $2,863,961 in the fourth quarter ended December 31, 2025, from $3,370,594 reported in the same year-ago period. Selling, General and Administrative (SG&A) Expenses: SG&A expenses increased”
ENDRA Life Sciences Inc. reported the quarter and year ended December 31, 2025 results: net income net loss of $3.2 million.
“in the fourth quarter of 2025 decreased to $1.6 million, compared with $4.3 million in the same period last year. As a result, the net loss in the fourth quarter of 2025 was $3.2 million, compared with a net loss of $4.2 million in the fourth quarter of 2024. 2025 Financial Results During 2025 the Company benefitted from actions taken throughout 2024 to”
J.Jill, Inc. reported the fiscal year ended January 31, 2026 results: revenue $596.5 million, net income Net Income was $27.9 million, EPS Net Income per Diluted Share was $1.82.
“For year ended January 31, 2026: • Net sales for year ended January 31, 2026 decreased 2.3% to $596.5 million compared to $610.9 million for year ended February 1, 2025. • Total company comparable sales for the year ended January 31, 2026, which includes comparable store and direct to consumer sales, decreased by 3.1% compared to the year ended February 1, 2025 • Direct to consumer net sales, which represented 48.2% of net sales, decreased 0.8% compared to year ended February 1, 2025. • Gross profit was $409.7 million compared to $429.9 million for year ended February 1, 2025. Gross margin was 68.7% compared to 70.4% for year ended February 1, 2025. The Company incurred approximately $7.5 million of incremental tariff costs net of vendor mitigation in fiscal 2025 compared to the prior year. • SG&A was $358.5 million compared to $353.4 million for year ended February 1, 2025. SG&A as a percentage of total net sales was 60.1% compared to 57.9% for year ended February 1, 2025. • Operating”
J.Jill, Inc. reported the fourth quarter ended January 31, 2026 results: revenue $138.4 million, net income Net Loss was $3.5 million, EPS Net Loss per Diluted Share was $0.23.
“For the fourth quarter ended January 31, 2026: • Net sales for the fourth quarter of fiscal 2025 decreased 3.1% to $138.4 million compared to $142.8 million for the fourth quarter of fiscal 2024. • Total company comparable sales, which includes comparable store and direct to consumer sales, decreased by 4.8% for the fourth quarter of fiscal 2025. • Direct to consumer net sales, which represented 53.5% of net sales, were up 2.6% compared to the fourth quarter of fiscal 2024. • Gross profit was $87.3 million compared to $94.8 million in the fourth quarter of fiscal 2024. Gross margin was 63.1% compared to 66.3% in the fourth quarter of fiscal 2024. The Company incurred approximately $4.5 million of incremental tariff costs, net of vendor mitigation, in the fourth quarter of fiscal 2025 compared to the prior year period. • SG&A was $87.0 million compared to $89.3 million in the fourth quarter of fiscal 2024. SG&A as a percentage of total net sales was 62.9% compared to 62.5% in the fourth”
FORUM MARKETS Inc updated its the fourth quarter and full year ended December 31, 2025 guidance (initiated).
“On March 31, 2026, Forum Markets, Incorporated (the “ Company ”) issued a press release announcing its financial results for the fiscal quarter and year ended December 31, 2025.”
Co-Diagnostics, Inc. reported full year ended December 31, 2025 results: revenue $0.6 million, net income net loss of $46.9 million, EPS $35.25 per share.
“the development of molecular diagnostic tests, today announced its financial results for the full year ended December 31, 2025. Full Year 2025 Financial Results: ● Revenue of $0.6 million, compared to $3.9 million in 2024, primarily due to lower grant revenue ● Operating expenses of $50.6 million, compared to $43.0 million in 2024, driven by a non-cash impairment”
Rekor Systems, Inc. reported the full year ended December 31, 2025 results: revenue $ 48,450, net income $(31,460).
“31, 2024. Revenues and Cost of Revenue, excluding Depreciation and Amortization Year ended December 31, Change 2025 2024 $ % (Dollars in thousands, except percentages) Revenue $ 48,450 $ 46,028 $ 2,422 5 % Cost of revenue, excluding depreciation and amortization 21,379 23,344 (1,965 ) -8 % Adjusted Gross Profit $ 27,071 $ 22,684 $ 4,387 19 % Adjusted Gross”
Bit Digital, Inc reported Fiscal Year 2025 results: revenue $113.6 million, net income $(80.3) million, EPS $(0.31) per diluted share.
“Total revenue for fiscal year 2025 was $113.6 million, a 5% increase compared to $108.0 million in fiscal year 2024.”
Catheter Precision, Inc. reported the quarter and year ended December 31, 2025 results: revenue $819 thousand, net income $17.2 million.
“create a compelling framework for accelerated growth and a potential re-rating as execution milestones are achieved. 2025 Full Year Financial Highlights ● 2025 Revenue of $819 thousand, a 95% increase over 2024 Revenue of $420 thousand. ● 2025 Gross Margin of 92.3% compared with 90.0% in 2024. ● Net Loss of $17.2 million of which $7.8 million was non-cash”
T Stamp Inc reported the year ended December 31, 2025 results: revenue $3.14 million, EPS $2.67 per share.
“Net recognized revenue for the year ended December 31, 2025 was $3.14 million, an increase of 2% from $3.08 million for the corresponding period in 2024.”
Mediaco Holding Inc. reported the twelve months ended December 31, 2025 results: revenue $133,336, net income $(66,223).
“% (12.9) % ADJUSTED EBITDA (1) $ (3,706) $ 1,733 (313.8) % 2025 Twelve Month Financial Summary Year ended December 31, Change (Dollars in thousands) 2025 2024 % NET REVENUES $ 133,336 $ 95,571 39.5 % NET LOSS $ (66,223) $ (1,302) 4986.3 % % Margin (1) (49.7) % (1.4) % ADJUSTED EBITDA (1) $ 7,266 $ (1,587) (558.0) % (1) Net Income margin is Net Income as a”
Mediaco Holding Inc. reported the quarter ended December 31, 2025 results: revenue $38,663.
“release and additional information on our website. 2025 Fourth Quarter Financial Summary Three Months Ended December 31, Change (Dollars in thousands) 2025 2024 % NET REVENUES $ 38,663 $ 32,804 17.9% NET LOSS (32,337) (4,244) 661.9% % Margin (1) (83.6) % (12.9) % ADJUSTED EBITDA (1) $ (3,706) $ 1,733 (313.8) % 2025 Twelve Month Financial Summary Year ended”
Skillz Inc. reported the fourth quarter and year ended December 31, 2025 results: revenue $30.0 million, net income Net loss of $17.9 million.
“to players worldwide, today reported financial results for the fourth quarter and fiscal year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights: • Revenue of $30.0 million • Gross profit of $26.5 million • Net loss of $17.9 million • Adjusted EBITDA 1 loss of $10.0 million • Paying monthly active users (PMAUs) 2 of 141 thousand • Average revenue”
GoHealth, Inc. reported financial results for the twelve months ended December 31, 2025.
“On March 31, 2026 , GoHealth, Inc. issued a press release announcing its financial results for the twelve months ended December 31, 2025.”
Edible Garden AG Inc reported financial results for year and quarter ended December 31, 2025.
“On March 31, 2026, Edible Garden AG Incorporated (the “Company”) issued a press release to report financial results for the year and quarter ended December 31, 2025.”
Latch, Inc. reported the year ended December 31, 2025 results: revenue $70.1 million, net income $(53.7) million.
“Total revenue of $70.1 million, a $13.5 million (24%) year-over-year increase”
BioAtla, Inc. reported fourth quarter and full year ended December 31, 2025 results: revenue Collaboration and other revenue was $2.0 million for the fourth quarter and full year 2025, net income Net loss for the fourth quarter of 2025 was $9.8 million, compared to a net loss of $14.9 million for the same period in.
“BioAtla Reports Fourth Quarter and Full Year 2025 Financial Results and business Highlights – Initiated a formal process to monetize assets – Implemented a restructuring plan to significantly reduce operating expenses and extend runway SAN DIEGO, March 31, 2026 – BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced its financial results for the full year and fourth quarter ended December 31, 2025 and provided business highlights.”
HCW Biologics Inc. reported the year ended December 31, 2025 results: revenue $54,232.
“Revenues for the years ended December 31, 2024 and 2025 were $2.6 million and $54,232, respectively.”
HCW Biologics Inc. reported the three months ended December 31, 2025 results: revenue $27,010.
“Revenues for the three months ended December 31, 2024 and 2025 were $394,804 and $27,010, respectively.”
Connect Biopharma Holdings Ltd reported financial results for the three and twelve months ended December 31, 2025.
“On March 31, 2026, Connect Biopharma Holdings Limited (the “Company”) issued a press release announcing its financial results for the fiscal year ended December 31, 2025.”
Nuvve Holding Corp. reported the fourth quarter ended December 31, 2025 results: revenue $1.95 million.
“battery projects which we anticipate will accelerate the scaling of our platform in North America, Europe and Japan.” 2025 Fourth Quarter Financial Review Total revenue was $1.95 million for the three months ended December 31, 2025, compared to $1.79 million for the three months ended December 31, 2024. The increase in revenue was attributed to increase in”
MiNK Therapeutics, Inc. reported the fourth quarter and full year ended December 31, 2025 results: net income net loss for the quarter ended December 31, 2025, was $2.6 million, or $0.56 per share.
“On March 31, 2026, MiNK Therapeutics, Inc. (the "Company") announced its financial results for the quarter and year ended December 31, 2025.”
LanzaTech Global, Inc. reported the fourth quarter and fiscal year ended December 31, 2025 results: net income $49.0 million.
“Net loss decreased to $49.0 million and Adjusted EBITDA (1) decreased to $71.3 million in 2025, compared to Net loss of $137.7 million and Adjusted EBITDA of $88.2 million in 2024, reflecting meaningful progress in underlying operating performance, driven by disciplined cost optimization initiatives.”
KORE Group Holdings, Inc. reported the quarter and full year ended December 31, 2025 results: revenue Revenue was $73.9 million, net income Net Loss decreased to $18.5 million.
“and Analytics, today reported financial and operational results for the quarter and full year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights • Revenue was $73.9 million, roughly flat to the same period last year, while Total Connections 1 increased to 20.9 million, up 6% from 19.7 million from the same period last year. • Net Loss decreased to”
AirJoule Technologies Corp. reported financial results for fourth quarter and year ended December 31, 2025.
“On March 30, 2026, AirJoule Technologies Corporation issued a press release announcing its financial and operational results for the fourth quarter and year ended December 31, 2025.”
GEN Restaurant Group, Inc. reported financial results for the fourth quarter and full year ended December 31, 2025.
“On March 31, 2026, GEN Restaurant Group, Inc. (the “Company”) issued a press release announcing its financial results for the quarter and fiscal year ended December 31, 2025.”
HeartCore Enterprises, Inc. reported full year ended December 31, 2025 results: revenue $9.0 million, net income $5.5 million.
“will continue to strengthen our focus on financial services and aim to drive sustainable growth and long-term stockholder value.” Full Year 2025 Financial Results Revenues were $9.0 million, compared to $22.7 million in the same period last year. The decrease was primarily due to receipt of $13 million in warrant revenue from one large Go IPO deal in the prior”
nCino, Inc. reported financial results for the fourth quarter and fiscal year ended January 31, 2026.
“On March 31, 2026, the Company issued a press release announcing its financial results for its fourth quarter and fiscal year ended January 31, 2026. A copy of the press release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.”
Jushi Holdings Inc. reported FY 2025 results: revenue 262.9 million, net income ($68.6 million).
“Financial Highlights Q4 2025 Total revenue of $68.3 million Gross profit and gross profit margin of $28.6 million and 41.9%, respectively Net loss of $15.6 million Adjusted EBITDA 1 and Adjusted EBITDA 1 margin of $13.9 million and 20.4%, respectively Cash, cash equivalents and restricted cash were $26.6 million as of December 31, 2025 Net cash flows provided by operations of $6.1 million FY 2025 Total revenue of $262.9 million Gross profit and gross profit margin of $114.0 million and 43.4%, respectively Net loss of $68.6 million Adjusted EBITDA 1 and Adjusted EBITDA 1 margin of $50.3 million and 19.1%, respectively Net cash flows provided by operations of $17.7 million”
Jushi Holdings Inc. reported Q4 2025 results: revenue 68.3 million, net income ($15.6 million).
“Financial Highlights Q4 2025 Total revenue of $68.3 million Gross profit and gross profit margin of $28.6 million and 41.9%, respectively Net loss of $15.6 million Adjusted EBITDA 1 and Adjusted EBITDA 1 margin of $13.9 million and 20.4%, respectively Cash, cash equivalents and restricted cash were $26.6 million as of December 31, 2025 Net cash flows provided by operations of $6.1 million FY 2025 Total revenue of $262.9 million Gross profit and gross profit margin of $114.0 million and 43.4%, respectively Net loss of $68.6 million Adjusted EBITDA 1 and Adjusted EBITDA 1 margin of $50.3 million and 19.1%, respectively Net cash flows provided by operations of $17.7 million”
AIRO Group Holdings, Inc. reported the fiscal year ended December 31, 2025 results: revenue $90.9 million, net income $(4.1) million. Guidance initiated.
“Full Year 2025 ● Revenue: $90.9 million compared to $86.9 million in 2024. ● Gross profit: $54.4 million, representing gross margin of 59.9%, compared to $58.3 million, representing gross margin of 67.1% in 2024. ● Operating loss: $(28.8) million, compared to $(17.4) million in 2024. ● Net loss: $(4.1) million, compared to $(38.7) million in 2024 ● EBITDA: $24.7 million, compared to $(13.1) million in 2024. ● Adjusted EBITDA: $5.7 million, compared to $33.7 million in 2024. ● Cash and liquidity: Cash of $74.4 million as of December 31, 2025.”
AIRO Group Holdings, Inc. reported the fourth quarter ended December 31, 2025 results: revenue $48.3 million, net income break-even results. Guidance initiated.
“Revenue for the fourth quarter of 2025 was $48.3 million, compared to $39.7 million in the fourth quarter of 2024, reflecting continued demand for the Company’s drone systems and deliveries incorporating upgraded capabilities for the RQ-35 Heidrun platform. Gross profit for the fourth quarter was $29.7 million, representing gross margin of 61.4%, compared to $27.8 million and 69.9% in the prior-year period. The change in margin reflects product mix and delivery timing, integration of upgraded system capabilities, and continued investment in business development and team expansion. Operating income for the quarter was $6.0 million, compared to $16.1 million in the fourth quarter of 2024, reflecting continued investment in engineering development, production scaling and public company infrastructure. We reported break-even results for the fourth quarter, compared to net loss of $(0.8) million in the prior-year quarter.”
Cadrenal Therapeutics, Inc. reported the fourth quarter and full year ended December 31, 2025 results: net income $3.0 million for the quarter ending December 31, 2025.
“Cadrenal Therapeutics, Inc., a Delaware corporation (the “Company”), issued a press release that included financial information for the fiscal year ended December 31, 2025.”
Nakamoto Inc. reported financial results for the fiscal quarter and year ended December 31, 2025.
“On March 30, 2026, Nakamoto Inc., a Delaware corporation (the “ Company ”) issued a press release, announcing the Company’s financial results for the fiscal quarter and year ended December 31, 2025.”
Massimo Group reported fiscal year ended December 31, 2025 results: revenue $71.8 million, net income $1.5 million.
“, compared to 29.7% in FY2024 ( +780 basis points ) ● Gross Profit: $26.9 million, compared to $32.5 million ● Net Income: $1.5 million, compared to $1.8 million ● Revenue: $71.8 million, compared to $109.3 million ● Cash at Year-End: $5.8 million, compared to $10.2 million Revenue for 2025 reflects a deliberate strategy to rebalance dealer inventory, reduce”
Binah Capital Group, Inc. reported full year 2025 results: revenue $187.1 million, net income $2.3 million, EPS $0.04.
“Full Year 2025 Key Highlights § Total advisory and brokerage assets as of December 31, 2025, grew 11% to $29.9 billion. § Total annual revenue increased by 10.7% to $187.1 million. § Annual Gross profit was $37.8 million, compared to $33.7 million in 2024. § Total annual operating expenses were $35.2 million, compared to $36.8 million in 2024. § Annual GAAP net income rose to $2.3 million, compared to a GAAP net loss of $4.6 million in 2024. § Annual GAAP diluted EPS was $0.04 compared to $(0.39) in the prior year. § Annual EBITDA increased to $5.4 million from $1.9 million in the prior year. § Adjusted EBITDA* increased to $6.5 million, compared to $6.3 million in 2024.”
Binah Capital Group, Inc. reported fourth quarter 2025 results: revenue $50.5 million, net income $0.2 million, EPS $0.01.
“Fourth Quarter 2025 Key Highlights § Total advisory and brokerage assets as of December 31, 2025, grew 11% year-over-year to $29.9 billion. § Total revenue grew 13.2% to $50.5 million. § Gross profit was $10.3 million, compared to $8.9 million in the prior-year period. § Total operating expenses were $10.5 million, compared to $9.5 million in the prior-year period, reflecting a stabilization in expense levels compared to prior year results that included non-recurring business combination costs. § GAAP net income rose to $0.2 million, compared to a GAAP net loss of $1.1 million in the fourth quarter of 2024. § GAAP diluted EPS was $0.01 compared to $(0.07) in the prior year quarter § EBITDA of $0.5 as compared to EBITDA of $1.0 in the prior year quarter which is driven primarily by the change in the income tax provision. § Adjusted EBITDA of $0.8 as compared to $2.2 million in the prior year quarter, which included an adjustment for business combination and re-financing costs incurred d”
T1 Energy Inc. reported financial results for the year ended December 31, 2025.
“On March 31, 2026, T1 Energy Inc., a Delaware corporation (the “Company”), issued a press release announcing its financial results for the fourth quarter and year ended December 31, 2025.”
T1 Energy Inc. reported the fourth quarter ended December 31, 2025 results: revenue $358.5 million.
“Achieved record quarterly module production for T1 of 1.13 GW, generating record net sales of $358.5 million, in Q4 2025.”
Nomadar Corp. reported the fiscal year ended December 31, 2025 results: revenue $921,940.
“normalized cost structure positions Nomadar to accelerate our transition into a scalable global sports and technology platform.” 2025 Full Year Financial Highlights ● Revenue: $921,940 ● Gross Profit: $477,082 ● Gross Margin: 51.8% ● Net Loss: $2,767,318 ● Shareholders’ Equity: $7,118,188 Operating Performance Revenue was $921,940 and $8,025 for the years ended”
Turn Therapeutics Inc. reported the year ended December 31, 2025 results: net income NET LOSS $ (3,194,080 ), EPS Basic and diluted net loss per common share $ (0.12 ).
“liability 380,442 - Amortization of deferred offering cost (496,948 ) - Interest income 29,583 28,709 Other income 176,520 - Total other income 2,664,568 28,709 NET LOSS $ (3,194,080 ) $ (1,768,415 ) Basic and diluted net loss per common share $ (0.12 ) $ (0.07 ) Weighted-average common shares outstanding, basic and diluted 27,716,045 26,643,432 Turn”
CALLAN JMB INC. reported the twelve months ended December 31, 2025 results: revenue $5.7 million.
“Revenues for the twelve months ended December 31, 2025, was $5.7 million compared to $6.6 million for the twelve months ended December 31, 2024.”
CALLAN JMB INC. reported the full year ended December 31, 2025 results: revenue $5.7 million.
“device without downloading additional software. Financial Highlights for the Full Year Ended December 31, 2025: ● Revenues for the twelve months ended December 31, 2025, was $5.7 million compared to $6.6 million for the twelve months ended December 31, 2024. The decrease in revenue was due to the decrease in demand for our emergency preparedness services by”
Elauwit Connection, Inc. reported Full Year Ended December 31, 2025 results: revenue $21.6, net income $(4.2).
“Financial Highlights (unaudited) Three Months Ended Full Year Ended (in $ millions) December 31, 2025 December 31, 2024 December 31, 2025 December 31, 2024 Revenues $ 6.1 $ 3.3 $ 21.6 $ 8.5 Gross Profit $ 0.5 $ 0.3 $ 4.0 $ 1.2 Operating Expenses $ 2.7 $ 1.3 $ 7.7 $ 4.4 Net Loss $ (2.3 ) $ (1.0 ) $ (4.2 ) $ (3.5 ) Adjusted EBITDA (Non-GAAP) 1 $ (2.2 ) $ (1.0 ) $ (3.7 ) $ (3.2 )”
Elauwit Connection, Inc. reported Three Months Ended December 31, 2025 results: revenue $6.1, net income $(2.3).
“Financial Highlights (unaudited) Three Months Ended Full Year Ended (in $ millions) December 31, 2025 December 31, 2024 December 31, 2025 December 31, 2024 Revenues $ 6.1 $ 3.3 $ 21.6 $ 8.5 Gross Profit $ 0.5 $ 0.3 $ 4.0 $ 1.2 Operating Expenses $ 2.7 $ 1.3 $ 7.7 $ 4.4 Net Loss $ (2.3 ) $ (1.0 ) $ (4.2 ) $ (3.5 ) Adjusted EBITDA (Non-GAAP) 1 $ (2.2 ) $ (1.0 ) $ (3.7 ) $ (3.2 )”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.